Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0001209191-21-059698

CHIEF FINANCIAL OFFICER sold 1,251 shares at $14.21 ($17,783)

  • CHIEF FINANCIAL OFFICER acquired 7,918 shares (option exercise)
  • CHIEF FINANCIAL OFFICER gave up 1,961 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Millar Kerri-Ann · CHIEF FINANCIAL OFFICER

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-23 Exercise or conversion : show line 1 in the form +6,667 12,433 D
2021-08-23 Shares withheld for taxes : show line 2 in the form −1,961 10,472 D
2021-10-01 Exercise or conversion : show line 3 in the form +1,251 $7.50 $9,383 11,723 D
2021-10-01 Sale : show line 4 in the form −1,251 $14.21 $17,783 10,472 D
Open-market sales · 1,251 sh · avg $14.21 · $17,783

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-08-23 Exercise or conversion : show line 5 in the form Restricted Stock Units −6,667 6,667 D
2021-10-01 Exercise or conversion : show line 6 in the form Stock Option (right to buy) −1,251 53,749 D
Loading xslF345X03/doc4.xml…